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Abstract 
 
Objectives: To evaluate the performance of screening for all stillbirths and those due to 
impaired placentation and unexplained or other causes by a combination of maternal factors, 
fetal biometry and uterine artery pulsatility index (UT-PI) at 19-24 weeks’ gestation and 
compare this performance to that of screening by UT-PI alone. 
 
Methods: This was a prospective screening study of 70,003 singleton pregnancies including  
69,735 live births and 268 (0.38%) antepartum stillbirths; 159 (59%) were secondary to 
impaired placentation and 109 (41%) were due to other or unexplained causes. Multivariate 
logistic regression analysis was used to develop a model for prediction of stillbirth based on a 
combination of maternal factors, fetal biometry and UT-PI. 
 
Results: Combined screening predicted 55% of all stillbirths, including 75% of those due to 
impaired placentation and 23% of those that were due to other causes or unexplained, at false 
positive rate of 10%; within the impaired placentation group the detection rate of stillbirth at 
<32 weeks’ gestation was higher than that of stillbirth at >37 weeks (88% vs 46%; p<0.001). 
The performance of screening by the combined test was superior to that of selecting the high-
risk group on the basis of UT-PI being above the 90th percentile for gestational age, which 
predicted 48% of all stillbirths, 70% of those due to impaired placentation and 15% of those 
that were due to other causes or unexplained. 
 
Conclusions: Second-trimester screening by a combination of UT-PI with maternal factors and 
fetal biometry can predict a high proportion of stillbirths and in particular those due to impaired 
placentation.   
  
Introduction 
 
Antepartum stillbirths can be broadly classified into those thought to be the consequence of 
impaired placentation and those due to other causes or being unexplained; the rationale of 
categorizing stillbirths according to the likely underlying cause is that antenatal interventions 
and preventive strategies could potentially be undertaken more effectively.1-3 In the case of 
impaired placentation related stillbirth a two stage preventative strategy could be adopted. The 
first stage, at 11-13 weeks, is aimed at improving placentation through such pharmacological 
interventions as low-dose aspirin and pravastatin in the high-risk group;4,5 first-trimester 
screening by a combination of maternal factors, uterine artery pulsatility index (UT-PI), fetal 
ductus venosus pulsatility index for veins (DV-PIV) and maternal serum placental growth factor 
could potentially detect 61% of stillbirths due to impaired placentation, at false positive rate 
(FPR) of 10%.6 The second stage, at 19-24 weeks aims to identify a high-risk group that would 
benefit from close monitoring for early diagnosis of preeclampsia (PE) and small for 
gestational age (SGA) fetuses and prevention of stillbirth by defining the best time for delivery. 
There is evidence that effective identification of pregnancies at high-risk of stillbirth can be 
achieved by measurement of UT-PI in the second-trimester; a screening study of 66,026 
singleton pregnancies, including 306 stillbirths, reported that in 64% of antenatal stillbirths due 
to PE and/or SGA the UT-PI was above the 90th percentile.7 
 
The objective of this study was to evaluate the performance of screening for all stillbirths and 
those due to impaired placentation and unexplained or other causes by a combination of 
maternal factors, fetal biometry and UT-PI at 19-24 weeks’ gestation and compare this 
performance to that of screening by UT-PI alone. 
 
 
Methods 
 
Study population 
 
The data for this study were derived from prospective screening for adverse obstetric 
outcomes in women attending for routine pregnancy care at 19+0-24+6 weeks’ gestation at 
King’s College Hospital and Medway Maritime Hospital, United Kingdom. We recorded 
maternal characteristics and medical history and performed ultrasound examination for 
measurement of fetal head circumference (HC), abdominal circumference (AC) and femur 
length (FL).8 Gestational age was determined from measurement of fetal crown-rump length 
(CRL) at 11-13 weeks or fetal head circumference at 19-24 weeks.8,9 Transvaginal colour 
Doppler ultrasound was used to visualize the left and right uterine arteries at the level of the 
internal os.10 Pulsed-wave Doppler was then used to obtain waveforms and when three similar 
consecutive waveforms are obtained the PI is measured, and the mean PI of the two vessels 
is calculated. The scans are carried out by sonographers who had received the Certificate of 
Competence in Doppler of The Fetal Medicine Foundation (http://www.fetalmedicine.com). 
Women with a mean uterine artery PI greater than 1.6 were followed up with growth scans at 
28, 32 and 36 weeks’ gestation. Women with normal uterine artery Doppler received routine 
antenatal care.  
 
Written informed consent was obtained from the women agreeing to participate in a study on 
adverse pregnancy outcome, which was approved by the Ethics Committee of each 
participating hospital. The inclusion criteria for this study were singleton pregnancies that 
delivered a phenotypically normal live birth or stillbirth at >24 weeks’ gestation. We excluded 
pregnancies with aneuploidies, major fetal abnormalities, those ending in a miscarriage, 
termination of pregnancy or stillbirths due to intrapartum causes. Data on pregnancy outcome 
were obtained from the maternity hospital records or the general practitioners of women. The 
hospital maternity records of all women with antepartum stillbirths were reviewed to determine 
if the death was associated with preeclampsia, abruption or the birthweight was <10th 
percentile for gestational age 11 or it was due to other causes or was unexplained.  
 
Statistical analysis 
 
Data from continuous variables were expressed as medians and interquartile ranges and from 
categorical data as n (%). Comparison of the maternal characteristics between the outcome 
groups was by the χ2-square test or Fisher’s exact test for categorical variables and Kruskal-
Wallis or Mann-Whitney U-test for continuous variables, respectively. A p value of < 0.05 was 
considered significant. Post-hoc Bonferroni correction was used for multiple comparisons. 
 
The observed measurements of fetal HC, AC and FL were expressed as the respective Z-
score corrected for gestational age.8 The observed measurements of UT-PI were log10 
transformed to ensure homogeneity of variance and make the distribution Gaussian and each 
measured value was expressed as a multiple of the normal median (MoM) after adjustment 
for those characteristics found to provide a substantial contribution to the log10 transformed 
value.12  
 
The a priori risk for stillbirths was estimated from the algorithm derived from multivariate 
logistic regression analysis of maternal characteristics and history as previously described.13 
Univariate and multivariate logistic regression analysis was then used to determine if the 
maternal factor-derived logit (a priori risk), Z-scores of HC, AC, FL and UT-PI MoM had a 
significant contribution in the prediction of stillbirth. The variables which provided a significant 
contribution in the multivariate analysis were used to determine the patient-specific risk of 
stillbirth using the equation odds/(1+odds), where odds=eY and Y was estimated from the 
coefficients of variables in the logistic regression analysis. The distribution of patient-specific 
risks was used to determine the performance of screening by receiver operating characteristic 
(ROC) curves analysis and the DR and FPR were estimated.  
 
Regression analysis of log10 UT-PI on gestational age at the time of measurement was used 
to construct a reference range. The performance of screening for stillbirth using the 90th and 
95th percentiles of UT-PI was estimated. 
 
The statistical software package SPSS 22.0 (IBM SPSS Statistics for Windows, Version 22.0. 
Armonk, NY: IBM Corp, 2013) and Medcalc (Medcalc Software, Mariakerke, Belgium) were 
used for the data analyses. 
 
 
Results 
 
Study population 
 
In total 70,003 singleton pregnancies fulfilled the entry criteria; there were 69,735 live births 
and 268 (0.38%) antepartum stillbirths including 159 (59%) secondary to impaired 
placentation and 109 (41%) due to other or unexplained causes. The maternal and pregnancy 
characteristics of the outcome groups are compared in Table 1. In total x of the 70,003 
pregnancies in this study were included in a previous one on prediction of stillbirth.14 
 
Fetal biometry and uterine artery PI in outcome groups 
 
In the stillbirth group, compared to live births, the Z-scores of HC, AC and FL were lower (-
0.26 vs 0.0, p<0.0001; -0.37 vs. 0.0, p<0.0001; -0.21 vs -0.01, p<0.0001, respectively), and 
UT-PI MoM was higher (1.38 vs 1.00, p<0.0001) (sTable 1, Figure 1). Similarly, in the stillbirths 
due to impaired placentation, compared to live births, the Z-scores of HC, AC and FL were 
significantly lower (-0.45 vs 0.0, p<0.0001; -0.70 vs. 0.0, p<0.0001; -0.48 vs -0.01, p<0.0001, 
respectively), and UT-PI MoM was higher (1.69 vs 1.00, p<0.0001); in the stillbirths due to 
unexplained causes there were no significant differences from live births in any of the 
biomarkers (sTable 1). 
 
In the impaired placentation group, there was a significant association between UT-PI MoM 
and gestational age at delivery (r=-0.412, p<0.0001); in the unexplained stillbirths the 
association was not significant (p=0.604). 
 
Prediction of stillbirth and performance of combined screening 
 
The results of univariate and multivariate regression analysis are shown in sTable 2. In the 
multivariate regression analysis, there was a significant contribution to the prediction of 
stillbirths due to impaired placentation from maternal factor derived a priori risk, Z-scores of 
HC, AC, FL and UT-PI MoM (R2=0.341; p<0.0001). 
 
The performance of screening for stillbirth is shown in Table 2 and Figure 2. The DR for all 
stillbirths, at  FPR of 10%, increased from 30% for maternal factors to 55% with addition of 
fetal biometry and UT-PI (p<0.0001). Within the impaired placentation group, the DR 
increased from 34% for maternal factors to 75% with addition of fetal biometry and UT-PI MoM 
(p<0.0001); the DR of stillbirth based on maternal factors, biometry and UT-PI was higher for 
stillbirths at <32 weeks’ gestation than those at >37 weeks (88% vs 46%; p<0.001). 
 
Performance of screening by UT-PI above the 90th and 95th percentiles for gestational age 
 
Log10 UT-PI decreased linearly with gestational age at 19-24 weeks’ gestation (intercept 
0.26593 [95%CI 0.24554 to 0.28633]; slope -0.01137 [95%CI -0.01230 to -0.01045]; 
p<0.0001). The relationship with gestational age was used to construct a reference range with 
median, 5th, 10th, 90th and 95th percentiles (sTable 3). 
 
The performance of screening for stillbirth by UT-PI above the 90th and 95th percentiles for 
gestational age is shown in Table 3, sTable 4 and Figure 3. In general, the performance of 
screening by this approach was inferior to that achieved by combined screening; in screening 
by UT-PI above the 90th percentile, compared to combined screening at fixed FPR of 10%, the 
DR for all stillbirths, unexplained stillbirths and those due to impaired placentation were 48% 
vs. 55%, 15% vs. 23% and 70% vs 75%, respectively (Table 2 and 3).   
 
 
Discussion 
 
Main findings of the study 
 
The findings of the study demonstrate that in our population about 60% of antepartum 
stillbirths are due to impaired placentation and 40% are unexplained or due to other causes. 
A model which combines maternal factors, UT-PI and fetal biometry at 19-24 weeks’ gestation 
can potentially predict about 75% of stillbirths due to impaired placentation, at 10% FPR; the 
performance of screening is better for stillbirths at <32 weeks’ gestation (88%) compared to 
those at term (46%).  
 
The performance of screening for stillbirth is superior by a model combining UT-PI with 
maternal factors and fetal biometry than UT-PI alone. Additionally, the approach utilizing 
Bayes theorem is that in addition to UT-PI, maternal factors and other potentially useful 
biomarkers can be combined to improve the performance of screening. 
 
Strengths and limitations 
 
The strengths of this screening study are first, examination of a large population of pregnant 
women attending for routine assessment at 19-24 weeks’ gestation, second, systematic 
recording of data on maternal characteristics and medical history to identify known risk factors 
associated with stillbirth, third, use of a specific methodology and appropriately trained doctors 
to measure UT-PI, fourth, expression of the values of UT-PI as MoMs after adjustment for 
factors that affect the measurements, and fifth, use of multivariate regression analysis to take 
into account possible interrelations between the different variables to define the relative 
predictive value of each factor.  
 
A potential limitation of the study is that the performance of screening by a model derived and 
tested using the same dataset is overestimated. An additional limitation is that pregnancies 
with high UT-PI were monitored more intensively and this would have inevitably prevented 
some stillbirths thereby reducing the potential performance of this biomarker. 
 
Comparison with other studies 
 
A previous study of 30,519 singleton pregnancies highlighted that increased UT-PI at 22-24 
weeks’ gestation was a better predictor of stillbirth due to impaired placentation, especially at 
<33 weeks, than unexplained stillbirth.15  
 
A screening study in 15,835 nulliparous and high-risk parous women with an obstetric history 
of placental syndromes, which included 144 (0.9%) stillbirths, reported that the risk of stillbirth 
was 7-fold higher in the group with high impedance to flow in the uterine arteries above the 
90th percentile at 19-24 weeks’ gestation, compared to those with values < 90th percentile. 16 
The DR of all stillbirth for Doppler indices > 90th percentile was 46%, which is similar to the 
48% observed in our study. 
 
A screening study of 65,819 singleton pregnancies, included 306 (0.46%) stillbirths and in 159 
(52.0%) of these there was impaired placentation.14 The study reported that high uterine artery 
PI at 20–24 weeks’ gestation, was observed in antepartum stillbirths associated with impaired 
placentation but not in intrapartum stillbirths or in antepartum stillbirths without PE, SGA or 
abruption. In the impaired placentation group uterine artery PI was inversely associated with 
gestational age at birth. The UT-PI was > 90th percentile in 81% of stillbirths due to impaired 
placentation at <32 weeks, in 42% at 33–36 weeks and in 34% at >37 weeks; the respective 
percentages for stillbirths without impaired placentation were 16, 25 and 12%.  
 
Clinical implications of the study 
 
Combined screening at 22 weeks’ gestation is effective in identifying pregnancies at high-risk 
of stillbirth, PE and SGA at <37 weeks’ gestation, but poor in the prediction of these 
complications occurring at >37 weeks.17,18 More effective screening for late PE and SGA can 
be achieved by screening at 36 weeks.19,20 Pharmacological intervention by prophylactic use 
of low-dose aspirin at 22 weeks is not useful in reducing the risk of PE, SGA or stillbirth.4,21 
Future studies will determine whether the prophylactic use of pravastatin5 and / or close 
monitoring and timely delivery in the high-risk group can reduce the rate of these 
complications. 
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Table 1. Maternal and pregnancy characteristics in pregnancies that had a stillbirth, stratified according to sub-groups, compared with 
pregnancies that had live births. 
 
Maternal characteristics 
Live births 
(n=69,735) 
All stillbirths 
(n=268) 
Unexplained 
(n=109) 
Impaired placentation 
(n=159) 
Age, median (IQR) 30.5 (25.8-34.5) 30.5 (25.8-35.4) 30.9 (26.1-35.5) 30.4 (25.5-35.4) 
Weight, median (IQR) 67.0 (59.2-78.0) 73.4 (63.7-85.2)* 71.6 (64.2-84.0)* 74.0 (63.5-85.8)* 
Height, median (IQR) 1.64 (1.60-1.69) 1.65 (1.60-1.68) 1.65 (1.62-1.68) 1.63 (1.60-1.68) 
Racial origin     
     Caucasian, n (%) 48,794 (70.0) 144 (53.7) 65 (59.6) 79 (49.7) 
     Afro-Caribbean, n (%) 15,053 (21.6) 103 (38.4) 39 (35.8)* 64 (40.3)* 
     South Asian, n (%) 2,775 (4.0) 9 (3.4) 1 (0.9) 8 (5.0) 
     East Asian, n (%) 1,363 (2.0) 5 (1.9) 1 (0.9) 4 (2.5) 
     Mixed, n (%) 1,750 (2.5) 7 (2.6) 3 (2.8) 4 (2.5) 
Method of conception     
     Spontaneous, n (%) 67,777 (97.2) 255 (95.1) 105 (96.3) 150 (94.3) 
     Assisted conception, n (%) 1,958 (2.8) 13 (4.9) 4 (3.7) 9 (5.7) 
Cigarette smoking, n (%) 7,478 (10.7) 35 (13.1) 14 (12.8) 21 (13.2) 
Chronic hypertension, n (%) 1,031 (1.5) 17 (6.3)* 2 (1.8) 15 (9.4)* 
SLE / APS, n (%) 132 (0.2) 4 (1.5)* 0 4 (2.5)* 
Diabetes mellitus, n (%) 638 (0.9) 7 (2.6) † 3 (2.8) 4 (2.5) 
Parity     
     Nulliparous, n (%) 34,279 (49.2) 132 (49.3) 56 (51.4) 76 (47.8) 
     Previous miscarriage, n (%) 883 (1.3) 4 (1.5) 2 (1.8) 2 (1.3) 
     Previous stillbirth, n (%) 604 (0.9) 15 (5.6)* 3 (2.8) 12 (7.5)* 
     Previous SGA, n (%) 2,315 (3.3) 12 (4.5) 2 (1.8) 10 (6.3) 
Inter-pregnancy interval, median (IQR)a 3.0 (2.0-5.1) 4.2 (2.2-7.1)* 3.9 (2.2-7.0) 4.3 (2.2-8.0)† 
 
Post hoc Bonferroni correction for multiple comparisons; † = p< 0.01; * = p< 0.001 
 
IQR=interquartile range; SLE=systemic lupus erythematosus; APS=anti-phospholipid syndrome; SGA= small for gestational age 
a Inter-pregnancy interval median (IQR) reported for parous women  
Table 2. Performance of screening for stillbirths by maternal factors and combination of 
maternal factors with fetal biometry and uterine artery pulsatility index at 19-24 weeks’ 
gestation at fixed false positive rates of 5% and 10%. 
 
Outcome  N AUROC (95% CI) 
Detection rates (95% CI) 
5% FPR 10% FPR 
All stillbirths 268  
     Maternal factors  0.652 (0.617-0.688) 19.0 (14.3-23.7) 29.5 (24.0-34.9) 
     + biometry  0.718 (0.683-0.754) 32.2 (26.6-37.8) 42.5 (36.6-48.4) 
     + UT-PI  0.748 (0.712-0.783) 41.8 (35.9-47.7) 52.6 (46.6-58.6) 
     + biometry + UT-PI  0.748 (0.711-0.785) 45.1 (39.1-51.0) 54.7 (48.7-60.6) 
Unexplained    
     Maternal factors 109 0.618 (0.565-0.672) 13.8 (7.3-20.3) 22.9 (15.0-30.8) 
Abnormal placentation  
All stillbirths 159    
     Maternal factors  0.675 (0.628-0.723) 22.6 (16.1-29.1) 34.0 (26.6-41.4) 
     + biometry  0.861 (0.830-0.893) 52.8 (45.0-60.6) 63.5 (56.0-70.9) 
     + UT-PI  0.874 (0.840-0.907) 62.3 (54.8-69.8) 73.6 (66.8-80.5) 
     + biometry + UT-PI  0.904 (0.875-0.933) 69.8 (62.7-76.9) 74.8 (68.1-81.6) 
< 32 weeks 90    
     Maternal factors  0.706 (0.641-0.770) 33.3 (23.6-43.0) 42.2 (32.0-52.4) 
     + biometry  0.941 (0.912-0.969) 76.3 (67.5-85.1) 83.4 (75.7-91.1) 
     + UT-PI  0.925 (0.890-0.961) 76.7 (68.0-85.4) 85.6 (78.4-92.9) 
     + biometry + UT-PI  0.952 (0.921-0.982) 85.6 (78.4-92.9) 87.8 (81.0-94.6) 
< 37 weeks 126    
     Maternal factors  0.699 (0.648-0.751) 26.2 (18.5-33.9) 35.7 (27.3-44.1) 
     + biometry  0.891 (0.859-0.924) 61.1 (52.6-69.6) 70.6 (62.6-78.5) 
     + UT-PI  0.909 (0.875-0.942) 73.0 (65.3-80.8) 81.7 (75.0-88.5) 
     + biometry + UT-PI  0.929 (0.899-0.959) 79.4 (72.3-86.5) 82.5 (75.9-89.1) 
> 37 weeks 33    
     Maternal factors  0.584 (0.476-0.693) 9.1 (1.7-18.8) 27.3 (12.1-42.5) 
     + biometry  0.736 (0.669-0.823) 20.2 (6.5-33.9) 36.4 (20.0-52.8) 
     + UT-PI  0.740 (0.654-0.825) 21.2 (7.1-34.9) 42.4 (25.5-59.3) 
     + biometry + UT-PI  0.810 (0.743-0.877) 33.3 (17.2-49.4) 45.5 (28.4-62.4) 
 
AUROC = area under receiver operating characteristic curves; CI = confidence interval; UT-
PI = uterine artery pulsatility index; FPR = false positive rate 
  
Table 3. Detection rate with 95% confidence interval of stillbirth in screening by uterine artery 
pulsatility index adjusted for gestational age.  
 
Outcome N 
Uterine artery pulsatility index cut-off 
95th percentile 90th percentile 
All stillbirths 268 100 (37.3; 31.5-43.1) 128 (47.8; 41.8-53.7) 
Unexplained  109 5 (4.6; 0.8-8.5) 16 (14.7; 8.1-21.4) 
Abnormal placentation 159 95 (59.7; 52.1-67.3) 112 (70.4; 63.3-77.5) 
     < 32 weeks 90 68 (75.6; 66.7-84.5) 76 (84.4; 76.9-91.9) 
     < 37 weeks 126 88 (69.8; 61.8-77.8) 101 (80.2; 73.2-87.1) 
     > 37 weeks 33 7 (21.2; 7.3-35.2) 11 (33.3; 17.2-43.4) 
 
  
 
Supplementary Table 1. Median and interquartile range of uterine artery pulsatility index (PI) and fetal biometry at 19-24 week’s gestation in 
pregnancies with livebirths compared to those that had a stillbirth 
 
Biomarker 
Live births 
(n=69,735) 
All stillbirths 
(n=268) 
Unexplained 
(n=109) 
Impaired placentation 
(n=159) 
Uterine artery pulsatility index (MoM) 1.00 (0.84-1.20) 1.38 (0.99-1.76)** 1.03 (0.83-1.26) 1.69 (1.33-2.01)** 
Head circumference z-score 0.00 (-0.31-0.33) -0.26 (-0.62-0.08)** 0.07 (-0.26-0.41) -0.45 (-0.96- -0.16)** 
Abdominal circumference z-score 0.00 (-0.39-0.40) -0.37 (-0.87-0.02)** 0.04 (-0.30-0.49) -0.70 (-1.52- -0.29)** 
Femur length z-score -0.01 (-0.33-0.34) -0.21 (-0.71-0.18)** 0.12 (-0.25-0.44) -0.48 (-1.07- -0.12)** 
 
MoM = multiple of the median; Significance value (p): Post hoc Bonferroni correction for multiple comparisons; * = p< 0.01; ** = p< 0.001 
 
 
Supplementary Table 2. Univariate and multivariate logistic regression analysis for the 
prediction of stillbirths due to impaired placentation by maternal factors and combination of 
uterine artery pulsatility index and fetal biometry at 19-24 week’s gestation 
 
 
PI = pulsatility index; MoM = multiple of the median; OR = odds ratio; CI = confidence interval 
  
Variables 
Univariate analysis Multivariate analysis 
OR (95% CI) P value OR (95% CI) P value 
Maternal factor derived logit (a priori risk) 14.52 (9.29-22.69) <0.0001 7.56 (4.46-12.81) <0.0001 
Log10 uterine artery PI MoM 22.75e4 (73.20e3-70.72e4) <0.0001 8.25e3 (2.39e3-28.47e3) <0.0001 
Head circumference z-score 0.07 (0.05-0.09) <0.0001 0.49 (0.33-0.72) <0.0001 
Abdominal circumference z-score 0.09 (0.07-0.12) <0.0001 0.32 (0.23-0.44) <0.0001 
Femur length z-score 0.15 (0.12-0.18) <0.0001 0.67 (0.50-0.89) 0.005 
Supplementary Table 3. Reference range for uterine artery pulsatlility index, with 95% 
confidence interval, at 19-24 weeks’ gestation. 
Gestational age N 
Uterine artery pulsatility index 
5th centile 10th centile 50th centile 90th centile 95th centile 
19 weeks 1048 
0.72 
(0.66-0.78) 
0.80 
(0.73-0.87) 
1.12 
(1.04-1.20) 
1.58 
(1.49-1.67) 
1.74 
(1.64-1.84) 
20 weeks 7633 
0.70 
(0.64-0.76) 
0.77 
(0.71-0.83) 
1.09 
(1.01-1.17) 
1.54 
(1.45-1.63) 
1.70 
(1.60-1.80) 
21 weeks 15,269 
0.68 
(0.62-0.74) 
0.75 
(0.69-0.81) 
1.06 
(0.98-1.14) 
1.50 
(1.41-1.59) 
1.65 
(1.56-1.74) 
22 weeks 34,134 
0.67 
(0.61-0.73) 
0.74 
(0.68-0.80) 
1.04 
(0.96-1.12) 
1.46 
(1.37-1.55) 
1.61 
(1.52-1.70) 
23 weeks 11,135 
0.65 
(0.59-0.71 
0.72 
(0.66-0.78) 
1.01 
(0.94-1.08) 
1.42 
(1.33-1.51) 
1.57 
(1.48-1.66) 
24 weeks 813 
0.63 
(0.57-0.69) 
0.70 
(0.64-0.76) 
0.98 
(0.91-1.05) 
1.39 
(1.30-1.48) 
1.53 
(1.44-1.62) 
 
  
Supplementary Table 4. Performance of screening for stillbirths and subgroups of stillbirths 
by uterine artery pulsatility index above the 90th or 95th percentile for gestational age. 
 
 
  
Stillbirth subgroups 
Gestation at stillbirth 
Any gestation <32 weeks <37 weeks >37 weeks 
Uterine artery pulsatility index (> 90th percentile) 
All stillbirths 128/268 (47.8) 81/113 (71.1) 110/171 (64.3) 18/97 (18.6) 
Impaired placentation group 112/159 (70.4) 76/90 (84.4) 101/126 (80.2) 11/33 (33.3) 
     Small for gestation 53/88 (60.2) 36/48 (75.0) 47/67 (70.1) 6/21 (28.6) 
     Preeclampsia 45/51 (88.2) 34/36 (94.4) 42/44 (95.5) 3/7 (42.9) 
     Small for gestation and / or preeclampsia 98/139 (70.5) 70/84 (83.3) 89/111 (80.2) 9/28 (32.1) 
     Placental abruption 14/20 (70.0) 6/6 (100.0) 12/15 (80.0) 2/5 (40.0) 
Unexplained group 16/109 (14.7) 5/23 (21.7) 9/45 (20.0) 7/64 (10.9) 
 Uterine artery pulsatility index (95th percentile) 
All stillbirths 100/268 (37.3) 69/113 (61.1) 90/171 (52.6) 10/97 (10.3) 
Impaired placentation group 95/159 (59.7) 68/90 (75.6) 88/126 (69.8) 7/33 (21.2) 
     Small for gestation 45/88 (51.1) 32/48 (66.7) 40/67 (59.7) 5/21 (23.8) 
     Preeclampsia 39/51 (76.5) 30/36 (83.3) 38/44 (86.4) 1/7 (42.3) 
     Small for gestation and / or preeclampsia 84/139 (60.4) 62/84 (73.8) 78/111 (70.3) 6/28 (21.4) 
     Placental abruption 11/20 (55.0) 6/6 (100.0) 10/15 (66.7) 1/5 (20.0) 
Unexplained group 5/109 (4.6) 1/23 (4.3) 2/45 (4.4) 3/64 (4.7) 
Figure 1. Box and whiskers plot of head circumference, abdominal circumference, femur 
length Z-score and uterine artery pulsatility index multiple of the median (MoM) in live births 
(a), unexplained stillbirths (b) and stillbirths due to impaired placentation (c). The bottom and 
top edges of each box represent the first and third quartiles, respectively; the band within the 
box represents the median value. 
 
Figure 2. Receiver–operating characteristics curves for prediction of stillbirth due to impaired 
placentation from maternal factors and maternal factors with biomarkers. 
 
Figure 3. Uterine artery pulsatility index in pregnancies with stillbirths at <37 weeks due to 
impaired placentation (left), stillbirths at >37 weeks due to impaired placentation (middle) and 
stillbirths due to other causes or unexplained (right) plotted on the reference ranges with 
gestation (___ median, - - - 10th and 90th percentiles, ….5th and 95th percentiles).  
 
 
